| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-10 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |